Cumulative sum analysis of the learning curve for video-assisted minilaparotomy donor nephrectomy in healthy kidney donors by �굹以�梨� et al.
Observational Study Medicine®
OPENCumulative sum analysis of the learning curve
for video-assisted minilaparotomy donor
nephrectomy in healthy kidney donors
Jee Soo Park, MDa, Hyun Kyu Ahn, MDa, Joonchae Na, MDa, Hyung Ho Lee, MDb,
Young Eun Yoon, MD, PhDc, Min Gee Yoon, BSa, Woong Kyu Han, MD, PhDa,d,
∗
Abstract
Video-assisted minilaparotomy surgery (VAMS) is a hybrid of open and laparoscopic surgical techniques, so has advantages of both
approaches. Here, we examined the learning curve for this procedure.
We retrospectively evaluated 50 consecutive patients who underwent VAMS donor nephrectomy performed by a single surgeon
(YEY) between March 2015 and March 2016. The learning curve was evaluated using the cumulative sum (CUSUM) method.
Measures of surgical performance included total operation time, warm ischemic time, and estimated blood loss.
The mean patient age, body mass index, and body surface area were 43.5 years, 23.8kg/m2, and 1.7m2, respectively. The
mean operation time and warm ischemic time were 160.0minutes and 124.4seconds. The learning curve of total operation time
was best modeled as a second-order polynomial with equation CUSUMOT (minutes)=–0.3802case number2+20.315case
number–41.333 (R2=0.7707). The curve included 3 unique phases: phase 1 (the initial 17 cases), which is the initial learning
curve; phase 2 (the middle 23 cases), expert competence, and phase 3 (the subsequent cases), mastery. In terms of warm
ischemic time and estimated blood loss, the initial learning was achieved after 16 cases and after 9 to 10 cases, one could
achieve competency.
The VAMS donor nephrectomy learning curve is shorter than for laparoscopic or robotic hand-assisted donor nephrectomy.
Surgeons can become familiar with the procedure and perform it without complications after approximately 16 to 17 operations.
Abbreviations: ANOVA = analysis of variance, ASA = American Society of Anesthesiologists, BMI = body mass index, BSA =
body surface area, CUSUM= cumulative sum, EBL= estimated blood loss, HAL= hand-assisted laparoscopic donor nephrectomy,
LDN = laparoscopic donor nephrectomy, LOS = length of stay, RHADN = robotic hand-assisted donor nephrectomy, VAMS =
video-assisted minilaparotomy surgery, WIT = warm ischemic time.
Keywords: cumulative sum (CUSUM), donor nephrectomy, learning curve, video-assisted minilaparotomy surgery (VAMS)Editor: Giuseppe Lucarelli.
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11. Introduction
Surgical instrumentation and technologic innovations have
tremendously improved surgical proﬁciency. However, surgeons
will fall behind if they fail to learn new techniques. Investigating
the learning curve is useful for assessing how surgeons acquire
novel operative techniques,[1] and assessing healthcare quality
using statistical process-control methods is becoming more
commonplace.[2] The cumulative sum (CUSUM) technique was
originally developed to monitor industrial sector performance
and quality but has been adopted in the medical ﬁeld to analyze
surgical technique learning curves.[3,4]
Laparoscopic donor nephrectomy (LDN) was developed to
meet the increasing demand for renal transplants and has become
the preferred organ recovery method for living donors since it has
advantages of less postoperative pain, decreased length of
hospital stay with rapid recovery, faster return to work, and
enhanced cosmesis.[5–8] Living donor transplants provide better
graft function and survival than deceased donor kidney trans-
plants.[9] Hand-assisted laparoscopic donor nephrectomy (HAL)
is considered an important step in LDN since it is easier to learn,
more rapid to perform, and is associated with less bleeding and
fewer intestinal complications than full laparoscopy.[10]
Video-assisted minilaparotomy surgery (VAMS) is a hybrid of
laparoscopic and open surgical techniques that does not require
pneumoperitoneum or gas insufﬂation. This makes it particularly
Table 1
Patient characteristics.
Characteristic (n=50)
Age, y 43.5 (12.1)
Sex Male 27 (54.0%)
Female 23 (46.0%)
Height, cm 166.0 (9.4)
Weight, kg 65.9 (11.6)
BMI, kg/m2 23.8 (2.6)
BSA, m2 1.7 (0.2)
ASA score 1 35 (70.0%)
Park et al. Medicine (2018) 97:17 Medicinesuitable for extracting an intact solid organ through a small
incision such as that required for living donor nephrectomy.[11]
We have reported the efﬁcacy, efﬁciency, and favorable surgical
outcomes by VAMS donor nephrectomy.[12–14] However,
although several studies have reported the learning curves of
LDN, HAL, and robotic hand-assisted donor nephrectomy
(RHADN),[15–18] the learning curve of VAMS donor nephrec-
tomy has not been described. In the present work, we estimated
the learning curve for VAMS donor nephrectomy using CUSUM
methodology.2 14 (28.0%)
3 1 (2.0%)
HTN, n (%) 6 (12.0%)
DM, n (%) 0 (0.0%)
TBc, n (%) 2 (4.0%)
Hepatitis, n (%) 1 (2.0%)
Kidney Right 5 (10.0%)
Left 45 (90.0%)
Intraoperative parameters
Operation time, min 160.0 (29.5)
Warm ischemic time, s 124.4 (14.9)
EBL, cm3 66.5 (68.0)
Postoperative outcomes
LOS, d 8.2 (1.2)
ASA=American Society of Anesthesiologists, BMI=body mass index, BSA=body surface area,
DM=diabetes mellitus, EBL= estimated blood loss, HTN=hypertension, LOS= length of stay, TBc=
pulmonary tuberculosis.
∗
Data are shown as mean (SD) or number of subjects (%).2. Patients and methods
Medical records of patients treated at Severance Hospital in
Seoul, South Korea were retrospectively retrieved after the study
was approved by the Institutional Review Board of the Yonsei
University Health System (project no: 4-2017-0457). A single
experienced urologist (YEY) performed 50 consecutive VAMS
donor nephrectomy surgeries between March 2015 and March
2016.
The VAMS technique was used in all donor nephrectomy
surgeries with the patient in the semilateral position. A piercing
abdominal wall elevator was used to secure the retroperitoneal
space for the operative area. The surgical techniques were
described previously.[11–13,19] The time from the ﬁrst incision to
the ﬁnal closure was deﬁned as the operation time. Demographic
data including patient age, sex, height, weight, body mass index
(BMI), body surface area (BSA), American Society of Anesthesi-
ologists (ASA) score, and history of hypertension and diabetes
mellitus were retrospectively retrieved. Intraoperative parameters
including operation time, warm ischemic time (WIT), and
estimated blood loss (EBL) were analyzed, as well as the hospital
length of stay (LOS). Laboratory test results of preoperative,
immediate postoperative, and 1 day after the operation are
included. The measure of surgical performance was composed of
3 distinct categories, operation time, WIT, and EBL.2.1. Cumulative sum analysis
The CUSUM technique was used for quantitative assessment of
the learning curve; it calculates the running total of differences
between the individual data points and themean of all data points
and can therefore be performed recursively.[1]
The 50 cases were ordered chronologically, from the earliest to
the latest surgery dates. The operation time of each case is deﬁned
as xi, and the mean operation time of all cases is m.
CUSUMOTn ¼
Xn
i¼1
ðxi mÞ
The CUSUMOT1 of the ﬁrst case was the difference between the
operation time for the ﬁrst case and the mOT. The CUSUMOT2 of
the second case was the previous case’s CUSUMOT\ added to the
difference between the operation time for the second case and
mOT. This recursive process continued until we calculated the
CUSUMOT for the last case. Similarly, additional parameters,
WIT and EBL, were evaluated using CUSUM method.2.2. Statistical analysis
The results are reported as mean (standard deviation) for
continuous variables and as percentage values for categorical
variables. To compare phases 1, 2, and 3, analysis of variance2(ANOVA) was used for continuous variables, and chi-square or
Fisher exact tests were carried out for categorical variables. SPSS
software version 23.0 (IBM Corp., Armonk, NY) was used for
the statistical analyses. All statistical tests were two-tailed, and a
P-value <.05 was considered statistically signiﬁcant.
3. Results
Patient characteristics are listed in Table 1. The study population
included 27 (54.0%) men and 23 (46.0%) women with a mean
age, BMI, and BSA of 43.5±12.1 years, 23.8±2.6kg/m2, and
1.7±0.2m2, respectively. The median ASA score was 1,
accounting for 70% of the study population. Six (12.0%)
patients had hypertension, but none had diabetes mellitus. Most
kidney donations were performed on the left kidney (45 cases,
90%). The mean operation time and WIT were 160.0±29.5
minutes and 124.4±14.9seconds, respectively. The mean EBL
was 66.5±68.0cm3.
Figure 1 shows the operation times plotted in chronological
case order, and the CUSUMOT learning curve was best modeled
as a second-order polynomial with equation CUSUMOT in
minutes equal to –0.3802case number2+20.315case
number–41.333, which had a high R2 value of 0.7707. The
CUSUMOT learning curve consisted of 3 unique phases: phase
1 (the initial 17 cases), phase 2 (the middle 23 cases), and phase
3 (the ﬁnal 10 cases). Comparisons between the 3 phases
identiﬁed by CUSUMOT analysis are presented in Tables 2 and
3. There were no signiﬁcant differences in demographic
characteristics among the 3 phases. Operation time was
signiﬁcantly decreased in phase 3 (P< .001) compared with
phase 1; however, the decrease was not signiﬁcant from phase 1
to phase 2 (P= .115). The WIT and EBL of phases 2 and 3 were
shorter and smaller than those of phase 1, but the differences
were not signiﬁcant.
Figure 1. Total operation time (black line) and cumulative sum (CUSUM)OT (blue line) plotted against case number. The red line represents the best ﬁt for the plot
using a second-order polynomial with equation CUSUMOT=–0.3802case number2+20.315case number–41.333 (R2=0.7707), corresponding to 3 distinct
phases of the total operation time.
Table 2
Interphase comparisons of patient characteristics and other parameters
∗
.
Phase 1 Phase 2 Phase 3
(0–17, n=17) (18–40, n=23) (41–50, n=10) P-value†
Patient characteristic
Age, y 46.2 (11.6) 42.5 (9.5) 41.0 (17.7) .523
Sex Male 10 (58.8%) 12 (52.2%) 5 (50.0%) .871
Female 7 (41.2%) 11 (47.8%) 5 (50.0%)
Height, cm 166.4 (7.6) 167.3 (11.1) 162.1 (7.7) .343
Weight, kg 65.2 (9.1) 67.4 (13.9) 63.4 (9.9) .634
BMI, kg/m2 23.5 (2.6) 23.8 (2.2) 24.2 (3.5) .812
BSA, m2 1.7 (0.1) 1.8 (0.2) 1.7 (0.1) .437
ASA score 1 9 (52.9%) 19 (82.6%) 7 (70.0%) .194
2 7 (41.2%) 4 (17.4%) 3 (30.0%)
3 1 (5.9%) 0 (0.0%) 0 (0.0%)
HTN, n (%) 2 (11.8%) 2 (8.7%) 2 (20.0%) .740
DM, n (%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
TBc, n (%) 1 (5.9%) 1 (4.3%) 0 (0.0%) 1.000
Hepatitis, n (%) 1 (5.9%) 0 (0.0%) 0 (0.0%) .540
Kidney Right 2 (11.7%) 1 (4.3%) 2 (20.0%) .264
Left 15 (88.2%) 22 (95.7%) 8 (80.0%)
Intraoperative parameters
Operation time, min 174.2 (21.8) 160.1 (30.7) 135.6 (23.7) .003
Warm ischemic time, s 130.6 (23.6) 121.3 (6.3) 121.0 (3.2) .280
EBL, cm3 91.5 (78.8) 52.2 (60.1) 57.0 (58.9) .174
Postoperative outcomes
LOS, d 8.2 (1.3) 8.3 (1.3) 7.8 (0.8) .520
ASA=American Society of Anesthesiologists, BMI=body mass index, BSA=body surface area, DM=diabetes mellitus, EBL= estimated blood loss, HTN=hypertension, LOS= length of stay, TBc=pulmonary
tuberculosis.
∗
Data are shown as mean (SD) or number of subjects (%).
† Calculated with analysis of variance for continuous variables and chi-square or Fisher exact tests for categorical variables.
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Table 3
Pre- and postoperative laboratory measurements, mean (SD).
Phase 1 Phase 2 Phase 3
(0–17, n=17) (18–40, n=23) (41–50, n=10) P-value
∗
Preop lab
WBC, /mL 6392.4 (1833.7) 6157.8 (2640.0) 5888.0 (1275.8) .842
RBC, 106/mL 4.7 (0.5) 6.5 (8.7) 4.9 (0.4) .592
Hb, g/dL 14.3 (2.0) 14.5 (1.6) 14.8 (1.6) .747
Hct (%) 42.2 (5.1) 42.7 (4.2) 43.6 (3.4) .747
Ca, mg/dL 9.1 (0.3) 9.1 (0.3) 9.2 (0.5) .467
P, mg/dL 3.5 (0.4) 3.6 (0.4) 3.8 (0.2) .219
Glucose, mg/dL 100.2 (9.5) 96.3 (11.1) 92.8 (9.2) .186
BUN, mg/dL 12.4 (2.8) 11.1 (2.2) 12.4 (3.1) .242
Creatinine, mg/dL 0.8 (0.2) 0.7 (0.2) 0.7 (0.1) .764
eGFR (MDRD), mL/min/1.73m2 105.1 (24.3) 109.8 (19.0) 114.2 (32.6) .706
Uric acid, mg/dL 4.8 (1.4) 5.0 (1.7) 5.1 (1.0) .101
Cholesterol, mg/dL 196.7 (30.0) 190.0 (28.6) 183.8 (43.4) .930
AST, IU/L 19.2 (4.1) 18.2 (5.4) 21.5 (10.2) .002
ALT, IU/L 19.2 (9.2) 18.3 (9.6) 19.8 (17.6) .245
Immediate postop lab
WBC, /mL 13,535.9 (3088.8) 14,880.0 (3586.6) 14,989.0 (2410.6) .365
RBC, 106/mL 4.2 (0.4) 4.4 (0.4) 4.4 (0.5) .241
Hb, g/dL 12.6 (1.4) 13.3 (1.3) 13.2 (1.7) .299
Hct (%) 37.6 (3.8) 39.2 (3.4) 39.4 (3.6) .301
Ca, mg/dL 8.0 (0.4) 8.3 (0.3) 8.3 (0.5) .050
P, mg/dL 3.0 (0.5) 3.2 (0.5) 3.2 (0.3) .395
Glucose, mg/dL 125.1 (23.7) 124.2 (17.4) 124.6 (15.9) .989
BUN, mg/dL 10.3 (1.9) 9.6 (2.1) 10.8 (3.6) .391
Creatinine, mg/dL 0.9 (0.2) 0.9 (0.2) 0.9 (0.1) .933
eGFR (MDRD), mL/min/1.73m2 84.2 (15.8) 84.9 (16.0) 86.8 (14.1) .912
Uric acid, mg/dL 3.9 (1.0) 4.4 (1.4) 4.4 (1.1) .410
Cholesterol, mg/dL 154.9 (28.9) 168.5 (29.2) 155.5 (31.3) .289
AST, IU/L 17.4 (4.3) 19.0 (6.7) 19.6 (5.6) .558
ALT, IU/L 16.3 (8.8) 18.4 (14.7) 13.5 (6.4) .544
Postop Lab
WBC, /mL 10,258.8 (3204.9) 10,588.3 (2463.4) 10,268.0 (2121.8) .913
RBC, 106/mL 3.9 (0.4) 4.1 (0.4) 4.0 (0.5) .621
Hb, g/dL 19.2 (30.9) 12.3 (1.2) 12.0 (1.6) .558
Hct (%) 35.2 (4.2) 36.2 (3.1) 35.5 (4.4) .689
Ca, mg/dL 8.0 (0.3) 8.0 (0.4) 8.0 (0.4) .998
P, mg/dL 3.6 (0.4) 3.7 (0.5) 3.6 (0.4) .866
Glucose, mg/dL 100.8 (24.1) 95.5 (16.4) 88.2 (19.3) .289
BUN, mg/dL 12.7 (2.8) 11.8 (2.7) 12.7 (3.5) .590
Creatinine, mg/dL 1.1 (0.3) 1.1 (0.3) 1.1 (0.2) .776
eGFR (MDRD), mL/min/1.73m2 65.5 (16.9) 67.4 (14.7) 70.3 (14.7) .741
Uric acid, mg/dL 3.8 (1.0) 4.3 (1.4) 4.4 (1.1) .387
Cholesterol, mg/dL 146.0 (25.4) 157.0 (26.5) 141.0 (29.1) .221
AST, IU/L 20.4 (2.6) 20.0 (4.8) 19.8 (5.3) .897
ALT, IU/L 14.8 (6.8) 15.8 (11.1) 11.8 (4.6) .487
ALT= alanine transaminase, AST= aspartate transaminase, BUN=blood urea nitrogen, Ca= calcium, Cr= creatinine, eGFR= estimated glomerular ﬁltration rate, Hb=hemoglobin, Hct=hematocrit, HDL-C=
high-density lipoprotein cholesterol, LDL-C= low-density lipoprotein cholesterol, MDRD=modiﬁcation of diet in renal disease, P=phosphorus, RBC= red blood cell, TC= total cholesterol, TG= triglyceride,
WBC=white blood cell.
∗
Calculated using analysis of variance.
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EBL, respectively. Both of the curves consisted of 3 unique phase
with initial 16 cases of phase 1, and additional 9 cases (WIT) and
10 cases (EBL) in phase 2.4. Discussion
This is the ﬁrst investigation into the learning curve for
performing VAMS donor nephrectomies in living donors. There
is increasing demand for living donor renal transplants due to
their superior graft survival. Many surgical techniques including
LDN, RHADN, HAL have been developed to improve outcomes4of both the donor and the recovered kidney. Our institution has
used the VAMS technique for donor nephrectomy since 1991
based on beneﬁts of the laparoscopic approach including shorter
hospital stays, pain duration, and recovery periods, as well as
those of the open approach such as no need for careful handling
of the kidney vessels.
Ratner et al[20] performed the ﬁrst clinically successful LDN at
John Hopkins University. LDN has many advantages of minimal
invasive surgery; however, it requires extensive vascular dissec-
tion, careful handling of the kidney and vessels, and rapid
specimen extraction to minimize WIT.[16] Several studies noted
that a certain level of experience is required to decrease technical
[21]
Figure 2. Warm ischemic time (black line) and cumulative sum (CUSUM)OT (blue line) plotted against case number. The red line represents the best ﬁt for the plot
using a second-order polynomial with equation CUSUMWIT=–0.1544case number2+7.8687case number–21.939 (R2=0.6637), corresponding to 3 distinct
phases of the warm ischemic time.
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signiﬁcant decrease in the mean operative time, EBL, orWIT even
after 381 cases. However, there was a signiﬁcant decrease in
donor complications after the ﬁrst 285 cases. Leventhal et al[22]
determined that complication rates signiﬁcantly decreased after a
surgeon performed 100 out of 500 donor nephrectomies. Similar
results have been reported in other studies.[23,24] Notably, 1 study
stated that the learning curve for RHADN was 74 cases.[18]
Compared with other techniques, VAMS donor nephrectomy
requires a shorter learning period before clinical complications
decrease.
For the comparison of WIT and EBL in LDN, HAL, and
RHADN with VAMS donor nephrectomy, VAMS donor
nephrectomy showed decreased in WIT and EBL compared
with LDN, HAL, and RHADN, except for the WIT of RHADN
according to the literature. TheWIT and EBL for the 381 cases of
LDN reported as 4.9±3.4minutes and 334±690.3cm3, respec-
tively.[21] Another study of 382 cases of LDN with single renal
artery showed WIT and EBL of 2.6±0.6minutes and 127±118
cm3.[22] Other study of LDN of 738 cases also showed similar
results of WIT and EBL of 169±90.8seconds and 128±194
cm3.[23] For HAL, the WIT and EBL were 3.6±1.5minutes and
128±70cm3 for 31 cases.[25] WIT and EBL of RHADN with
signle renal artery was 98±20seconds and 72±173cm3.[18]
This study evaluated a single surgeon’s operative competency
based on operation time and divided the cohort into phases
corresponding with the surgeon’s learning curve. The CUSUM
technique was previously used in pediatric cardiac surgery[26] and
is still used to monitor cardiac surgeon performance and patient
outcomes.[27] In terms of operation time, our CUSUM analysis5showed that phase 1 (17 cases), a surgeon with no experience in
donor nephrectomy could complete the initial learning phase.
After additional 23 cases, one could achieve expert competency.
In terms ofWIT and EBL, initial learning phase could be achieved
in 16 cases which are similar to CUSUM analysis in operation
time. However, about 9 to 10 cases were required to achieve
expert competency in terms of WIT and EBL which are shorter
than those required for operation time. The time required to
achieve competency of VAMS donor nephrectomy which are
represented by WIT and EBL is shorter than those required to
minimize operation time. After achieving competency of
procedure in VAMS donor nephrectomy, than surgeon could
reduce the operation time.
High BMI, previous operation history, previous recurrent
pyelonephritis history, congenital anomaly such as horseshoe
kidney and duplication of ureter, complicated anomaly of renal
vessels, and familiarity with the surgical devices would affect the
surgical performance in initial phase of any surgery associated
with donor nephrectomy. However, we have not performed
donor nephrectomy in patients with previous operation history,
previous recurrent pyelonephritis history, and congenital anom-
aly. According to our experiences, high BMI, complicated
anomaly of renal vessels, and familiarity with the surgical devices
have affected the surgical performance at phase 1. However,
surgeon became familiar with the VAMS devices after phase 1
with 17 cases but BMI and complicated renal vessels still affected
the performance at phase 2. After phase 3, surgeon was
competent without any factors affecting the performance.
There are several possible reasons why VAMS donor
nephrectomy has a shorter learning curve than other techniques.
y = -0.2481x 2 + 13.051x - 17.802
R² = 0.122
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Figure 3. Estimated blood loss (black line) and cumulative sum (CUSUM)OT (blue line) plotted against case number. The red line represents the best ﬁt for the plot
using a second-order polynomial with equation CUSUMEBL=–0.2481case number2+13.051case number–17.802 (R2=0.122), corresponding to 3 distinct
phases of the estimated blood loss.
Park et al. Medicine (2018) 97:17 MedicineFirst, VAMS is a hybrid of open and laparoscopic surgeries. Both
laparoscopic and robot-assisted approaches employ needle
drivers that many ﬁnd difﬁcult to use. However, VAMS does
not require laparoscopic equipment handling. Second, the use of
telescope with a magniﬁed view and an internal light source
provides clear, direct surgical observation. Third, VAMS
employs an extraperitoneal approach, which has no bowel
injury with low morbidity. The surgeon can freely perform the
operation without fear of bowel injury, and there is no need to
consider adhesiolysis, thus shortening the learning curve. Fourth,
VAMS is easily converted to open surgery in the event of a
vascular accident.[19,28]
There are several limitations of this study. First, we only
analyzed cases for a single surgeon, and future investigations
including outcomes for multiple surgeons in different centers are
needed to verify our results. Second, although there were no
differences in patient characteristics among the different phases in
our study, selection bias could have affected the learning curve.5. Conclusion
To our knowledge, this is the ﬁrst analysis with CUSUM
identifying 3 unique learning curve phases for VAMS donor6nephrectomy. The surgeon completes the initial learning phase
of VAMS donor nephrectomy after 16 to 17 cases, which is
comparably shorter than other techniques. In terms of
operation time, after 40 cases, and in terms of WIT and
EBL, after 9 to 10 cases, a surgeon can effectively perform
VAMS donor nephrectomy with optimized WIT, total opera-
tion time, and low EBL.Author contributions
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